Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6RTJ

Thioredoxin glutathione reductase from Schistosoma mansoni in complex with 1-[(dimethylamino)methyl]-2-naphthol at 1 hour of soaking

Summary for 6RTJ
Entry DOI10.2210/pdb6rtj/pdb
DescriptorThioredoxin glutathione reductase, FLAVIN-ADENINE DINUCLEOTIDE, TETRAETHYLENE GLYCOL, ... (7 entities in total)
Functional Keywordsfragment, secondary site, schistosomiasis, fad/nad linked reductase, flavoprotein, time-resolved structural studies
Biological sourceSchistosoma mansoni
Total number of polymer chains1
Total formula weight66479.33
Authors
Angelucci, F.,Silvestri, I.,Fata, F.,Williams, D.L. (deposition date: 2019-05-24, release date: 2020-01-08, Last modification date: 2024-10-09)
Primary citationSilvestri, I.,Lyu, H.,Fata, F.,Banta, P.R.,Mattei, B.,Ippoliti, R.,Bellelli, A.,Pitari, G.,Ardini, M.,Petukhova, V.,Thatcher, G.R.J.,Petukhov, P.A.,Williams, D.L.,Angelucci, F.
Ectopic suicide inhibition of thioredoxin glutathione reductase.
Free Radic Biol Med, 147:200-211, 2020
Cited by
PubMed Abstract: Selective suicide inhibitors represent a seductively attractive approach for inactivation of therapeutically relevant enzymes since they are generally devoid of off-target toxicity in vivo. While most suicide inhibitors are converted to reactive species at enzyme active sites, theoretically bioactivation can also occur in ectopic (secondary) sites that have no known function. Here, we report an example of such an "ectopic suicide inhibition", an unprecedented bioactivation mechanism of a suicide inhibitor carried out by a non-catalytic site of thioredoxin glutathione reductase (TGR). TGR is a promising drug target to treat schistosomiasis, a devastating human parasitic disease. Utilizing hits selected from a high throughput screening campaign, time-resolved X-ray crystallography, molecular dynamics, mass spectrometry, molecular modeling, protein mutagenesis and functional studies, we find that 2-naphtholmethylamino derivatives bound to this novel ectopic site of Schistosoma mansoni (Sm)TGR are transformed to covalent modifiers and react with its mobile selenocysteine-containing C-terminal arm. In particular, one 2-naphtholmethylamino compound is able to specifically induce the pro-oxidant activity in the inhibited enzyme. Since some 2-naphtholmethylamino analogues show worm killing activity and the ectopic site is not conserved in human orthologues, a general approach to development of novel and selective anti-parasitic therapeutics against schistosoma is proposed.
PubMed: 31870799
DOI: 10.1016/j.freeradbiomed.2019.12.019
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

236963

PDB entries from 2025-06-04

PDB statisticsPDBj update infoContact PDBjnumon